R01NR020610
Project Grant
Overview
Grant Description
Comparative Mechanisms (Mediators, Moderators) of Psychosocial Chronic Pain Treatments
Chronic musculoskeletal pain (CP) is a major public health concern. A number of psychosocial treatments have emerged in recent decades to help address this problem. These interventions have been shown to be efficacious when compared to largely inert control conditions; however, recent meta-analyses indicate that most of these treatments are characterized by modest effects on primary outcomes. This is a critical shortcoming of these otherwise promising approaches.
Rather than attempting to boost efficacy only by developing new and hopefully more powerful interventions, we can also look within our already proven treatments for ways to enhance the magnitude of treatment effects. One strategy is to increase our understanding of treatment mediators. Studies of mediators are needed that directly compare different treatments with each other to determine which mediators are treatment-specific, which are shared across treatments, and which contribute the most to clinical outcomes. The findings from such research could be used to inform adaptations to existing treatment that enhance their benefits.
A second strategy for increasing the beneficial effects of existing treatments is to identify the patient characteristics that moderate treatment responses. Research is needed that is guided by theoretical models and that tests moderators across multiple treatments. Identifying subgroups of patients more likely to respond to one or another treatment can advance precision medicine by informing a priori patient-treatment matches that can optimize treatment effects.
We will compare the mechanisms and moderators of cognitive-behavioral therapy (CBT), acceptance and commitment therapy (ACT), and emotional awareness and expression therapy (EAET). Examining the mediators and moderators of these treatments holds great potential for advancing treatment development and enhancing treatment efficacy.
Adults with chronic spinal (axial) pain (N=460) will be randomly assigned to CBT, ACT, EAET, and to treatment-as-usual (TAU). Aim 1 is to identify specific and shared mediators across treatments. Aim 2 is to identify moderators across treatments. This project can increase the effects of our psychosocial chronic pain treatments by identifying the most powerful treatment mechanisms – specific and shared -- and revealing for whom the mediator outcome pathways are strongest. Via increased understanding of mediators and moderators, more effective pain treatment approaches can be developed, tested, and implemented.
Chronic musculoskeletal pain (CP) is a major public health concern. A number of psychosocial treatments have emerged in recent decades to help address this problem. These interventions have been shown to be efficacious when compared to largely inert control conditions; however, recent meta-analyses indicate that most of these treatments are characterized by modest effects on primary outcomes. This is a critical shortcoming of these otherwise promising approaches.
Rather than attempting to boost efficacy only by developing new and hopefully more powerful interventions, we can also look within our already proven treatments for ways to enhance the magnitude of treatment effects. One strategy is to increase our understanding of treatment mediators. Studies of mediators are needed that directly compare different treatments with each other to determine which mediators are treatment-specific, which are shared across treatments, and which contribute the most to clinical outcomes. The findings from such research could be used to inform adaptations to existing treatment that enhance their benefits.
A second strategy for increasing the beneficial effects of existing treatments is to identify the patient characteristics that moderate treatment responses. Research is needed that is guided by theoretical models and that tests moderators across multiple treatments. Identifying subgroups of patients more likely to respond to one or another treatment can advance precision medicine by informing a priori patient-treatment matches that can optimize treatment effects.
We will compare the mechanisms and moderators of cognitive-behavioral therapy (CBT), acceptance and commitment therapy (ACT), and emotional awareness and expression therapy (EAET). Examining the mediators and moderators of these treatments holds great potential for advancing treatment development and enhancing treatment efficacy.
Adults with chronic spinal (axial) pain (N=460) will be randomly assigned to CBT, ACT, EAET, and to treatment-as-usual (TAU). Aim 1 is to identify specific and shared mediators across treatments. Aim 2 is to identify moderators across treatments. This project can increase the effects of our psychosocial chronic pain treatments by identifying the most powerful treatment mechanisms – specific and shared -- and revealing for whom the mediator outcome pathways are strongest. Via increased understanding of mediators and moderators, more effective pain treatment approaches can be developed, tested, and implemented.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Chicago,
Illinois
606123833
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 06/30/26 to 06/30/27 and the total obligations have increased 461% from $545,703 to $3,064,088.
Rush University Medical Center was awarded
Enhancing Chronic Pain Treatment Efficacy: Mechanisms & Moderators Study
Project Grant R01NR020610
worth $3,064,088
from the National Institute of Nursing Research in September 2022 with work to be completed primarily in Chicago Illinois United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.361 Nursing Research.
The Project Grant was awarded through grant opportunity Research Project Grant (Parent R01 Clinical Trial Required).
Status
(Ongoing)
Last Modified 6/22/26
Period of Performance
9/26/22
Start Date
6/30/27
End Date
Funding Split
$3.1M
Federal Obligation
$0.0
Non-Federal Obligation
$3.1M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01NR020610
Transaction History
Modifications to R01NR020610
Additional Detail
Award ID FAIN
R01NR020610
SAI Number
R01NR020610-2103647809
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N200 NIH National Institute of Nursing Research
Funding Office
75N200 NIH National Institute of Nursing Research
Awardee UEI
C155UU2TXCP3
Awardee CAGE
3F752
Performance District
IL-07
Senators
Richard Durbin
Tammy Duckworth
Tammy Duckworth
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of Nursing Research, National Institutes of Health, Health and Human Services (075-0889) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,577,468 | 100% |
Modified: 6/22/26